Evidence map›Paper›PMID 25980548›Full record

ArticleScientific reports2015

Modulation of Igβ is essential for the B cell selection in germinal center.

Kagefumi Todo, Orie Koga, Miwako Nishikawa, Masaki Hikida

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Programmed Death-1 Restrains the Germinal Center in Type 1 Diabetes.Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kagefumi TodoCenter for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University Yoshidakonoecho, Sakyoku, Kyoto 606-8501, Japan.
Orie KogaCenter for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University Yoshidakonoecho, Sakyoku, Kyoto 606-8501, Japan.
Miwako NishikawaCenter for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University Yoshidakonoecho, Sakyoku, Kyoto 606-8501, Japan.
Masaki HikidaCenter for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University Yoshidakonoecho, Sakyoku, Kyoto 606-8501, Japan.
Kyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The positive and negative selection of antigen-reactive B cells take place in the germinal center (GC) during an immune responses. However, the precise molecular mechanisms underlying these selection machineries, including the involvement of antigen receptor signaling molecules, remain to be elucidated. We found that expression levels of Igα and Igβ, which are the essential components of B cell antigen-receptor complex, were differentially regulated in GC B cells and that the expression of Igβ was more prominently down-regulated in a portion of GC B cells. The suppression of Igβ down-regulation reduced the number of GL7(+)GC B cells and the affinity maturation in T-dependent responses was markedly impaired. In addition, the disease phenotypes in autoimmune-prone mice were ameliorated by blocking of Igβ down-regulation. These results suggest that Igβ down-regulation is involved in the normal positive selection in GC and the accumulation of autoreactive B cells in autoimmune-prone mice.

Indexed as

AnimalsAntibody FormationAutoimmunityB-LymphocytesB-Lymphocyte SubsetsCD79 AntigensCell MembraneDown-RegulationGene Expression RegulationGerminal CenterImmunoglobulin Class SwitchingInterleukin-21InterleukinsMiceSomatic Hypermutation, ImmunoglobulinCD79 AntigensInterleukin-21Interleukins

Identifiers

PMID25980548
PMCPMC4650814
OpenAlexW2257236099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.